Our previous study targeting the molecular mechanisms that occur in paired tumor specimens obtained from patients with and without recurrence, have suggested that the BDNF signaling pathway is involved in the up-regulation of genes that are present in stage II and stage IIIA recurrent breast cancer [20]. The gene discussed is BDNF; the disease is neoplasm.